| 1. Develop guidance for stakeholders |
A joint guidance supporting the implementation of the GHS and interpretation of technical issues and requirements in both Canada and the U.S. |
- Coordination, to the greatest extent possible, of Canada and U.S. updates to guidance, including those to align with the publication of revisions to the UN Globally Harmonized System of Classification and Labeling (GHS Purple Book). (Ongoing)
|
- This activity is ongoing. Health Canada and U.S. OSHA continue to discuss the coordination of updates to their guidance.
|
- Issue joint compliance promotion materials as needed such as joint guidance on the preparation of specific section of the SDS (sections 2, 3, 8 and 9), and how to comply with requirements of the Hazardous Products Regulations (HPR) and the Hazard Communication Standard 2012 (ongoing).
|
- This activity is ongoing. Health Canada and U.S. OSHA continue to discuss the development of joint compliance promotion materials, as necessary.
|
- Issue ad hoc materials to support interpretations on regulatory and technical issues to increase compliance on issues related to GHS implementations in both countries, as may be necessary. (Ongoing)
|
- This activity is ongoing. Health Canada and U.S. OSHA continue to discuss the development of ad hoc materials to support interpretations of regulatory and technical issues, as necessary.
|
- Host a joint Canada/U.S. stakeholder meeting to provide progress on collaborative efforts and gain stakeholders input on priorities to guide development. (Summer 2020)
|
- This activity is postponed to a later date due to COVID-19.
|
| 2. Coordinate common positions and participate at the United Nations Sub-committee of Experts on the GHS (UNSCEGHS) |
Establishment of forward plans, where appropriate, to address international issues raised at the UNSCEGHS. |
- Inform stakeholders of issues prior to the UNSCEGHS international meetings and solicit feedback. (Bi-annual - June and November)
|
- This activity is completed. Canadian stakeholders were informed of issues in May 2019, October 2019, May 2020 and October 2020.
|
- Convene the working group for workplace chemicals in advance of international meetings to create common positions, where appropriate. (Bi-annual - July and December)
|
- This activity is completed. Working group meetings were held in June 2019, November 2019, June 2020 and November 2020.
|
- Coordinate joint updates to stakeholders on issues that arise from the international discussions. (Annually)
|
- This activity is ongoing. Health Canada provided updates to stakeholders at meetings in April 2019 and December 2019. Since the 39th session of the UNSCEGHS was delayed to December 2020 due to COVID-19, updates to stakeholders were communicated via email in February 2021.
|
| 3. Maintain alignment on the implementation of the GHS |
Having one label and one SDS, where possible, that would be acceptable in both countries, without reducing the level of safety or protection to workers. |
- Convene meetings between U.S. OSHA and Health Canada to discuss items from the most recent revisions of the GHS Purple Book for proposed adoption in the Canadian and U.S. regulations. (Ongoing)
|
- This activity is ongoing. Health Canada and U.S. OSHA discussed items at meetings in 2019.
|
- Communication of GHS updates to stakeholders and potential impacts for Canada and the U.S. related to alignment with revisions of the GHS Purple Book. (Ongoing)
|
- This activity is ongoing. GHS updates were provided to stakeholders at meetings in 2019 and 2020.
|
- Within the existing working group for work place chemicals, identification of potential regulatory amendments as a result of publication of future revisions of the GHS Purple Book. (Ongoing)
|
- This activity is ongoing. Health Canada and U.S. OSHA discuss future regulatory amendments on an ongoing basis.
|
- Where variances occur between Canada and the U.S. regarding adoptions of future revisions of the GHS Purple Book, communication of impact and, where appropriate, forward plan to stakeholders. (Ongoing)
|
- This activity is ongoing.
|
- Discuss variances and implementation issues – concentration ranges and small packages exemptions. (Ongoing)
|
- This activity is ongoing. Health Canada and U.S. OSHA continue to discuss variances and implementation issues.
|